LOQUS23 THERAPEUTICS Funding: $43M Raised, Series A (2024)
LOQUS23 THERAPEUTICS is a Biotech company based in Cambridge, United Kingdom. It has raised $43M in total funding. Latest round: Series A.
LOQUS23 THERAPEUTICS funding overview
LOQUS23 THERAPEUTICS is a Biotech company based in Cambridge, United Kingdom. LOQUS23 THERAPEUTICS has raised $43M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2024. The round record for LOQUS23 THERAPEUTICS runs through 2024; nothing later has been disclosed. Investors on record include Forbion, SV Health Investors’ Dementia Discovery Fund, Novartis Venture Fund. 3 distinct backers are named across the disclosed rounds.
LOQUS23 THERAPEUTICS at a glance
Total raised
$43M
Latest round
Series A
Latest round date
October 2024
Industry
Biotech
Headquarters
Cambridge, United Kingdom
Notable investors
Forbion, SV Health Investors’ Dementia Discovery Fund, Novartis Venture Fund
Frequently asked about LOQUS23 THERAPEUTICS funding
How much has LOQUS23 THERAPEUTICS raised?
LOQUS23 THERAPEUTICS has raised $43M in total disclosed funding across the rounds on record.
Who has invested in LOQUS23 THERAPEUTICS?
Forbion, SV Health Investors’ Dementia Discovery Fund, Novartis Venture Fund are named among the investors backing LOQUS23 THERAPEUTICS.
What was the latest LOQUS23 THERAPEUTICS funding round?
The most recent disclosed round is a Series A, announced in October 2024.
Where is LOQUS23 THERAPEUTICS based?
LOQUS23 THERAPEUTICS is based in Cambridge, United Kingdom.
What sector does LOQUS23 THERAPEUTICS operate in?
LOQUS23 THERAPEUTICS is tracked under Biotech from Cambridge, United Kingdom, with $43M in disclosed funding.
When did LOQUS23 THERAPEUTICS last raise?
The last disclosed LOQUS23 THERAPEUTICS round closed in October 2024 at Series A.
Round data for LOQUS23 THERAPEUTICS is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cambridge and backer lists below.
